1.Evidence summary of early mobilization in awake patients on extracorporeal membrane oxygenation
Jiangshuyuan LIANG ; Fei ZENG ; Meijuan LAN ; Peipei GU ; Lingyun CAI ; Luyao GUO ; Yan ZHU ; Ge GUO
Chinese Journal of Nursing 2024;59(3):345-352
Objective To retrieve,evaluate and summarize the best evidence of early mobilization in awake patients on extracorporeal membrane oxygenation,and to provide a reference for clinical practice.Methods UpToDate,BMJ Best Practice,Registered Nurses'Association of Ontario,National Guideline Clearinghouse,National Institute for Health and Care Excellence,Yimaitong,Joanna Briggs Institute Library,Cochrane Library,CINAHL,PubMed,SinoMed,CNKI,Wanfang Database,Vip Database and Extracorporeal Life Support Organization Website were researched to collect the literature,including clinical guidelines,expert consensuses,evidence summaries,systematic reviews,and well-designed original studies.The time limit for retrieval was until June 2023.The quality of literature and the level of evidence were evaluated by the evaluation criteria and evidence grading system of J BI Evidence-Based Health Care Center.Results 14 pieces of the literature were included,including 2 clinical guidelines,4 expert consensuses,5 systematic reviews,2 cohort studies and 1 case series.Totally 33 pieces of evidence were summarized,covering 7 aspects:adaptation conditions for the implementation of awake ECMO,team composition,comprehensive assessment,pre-mobilization preparation,mobilization content,prevention and control of adverse events,and effect evaluation.Conclusion The study summarizes the best evidence of early mobilization in awake patients on extracorporeal membrane oxygenation.It is suggested that medical institutions establish a professional team for the early mobilization of awake ECMO patients,apply the best evidence to standardize the early mobilization process,and formulate an individualized mobilization program.
2.An investigation of literature reading report among professional postgraduate students in pediatrics
Rui GU ; Peipei SHI ; Qin WANG ; Jianjiang ZHANG
Chinese Journal of Medical Education Research 2024;23(6):748-752
Objective:To investigate the current status of literature reading report and clinical research ability among professional postgraduate students in pediatrics, and to provide a reference for cultivating high-quality pediatric talents.Methods:A total of 91 professional postgraduate students majoring in pediatrics were selected as research subjects from five affiliated hospitals of Zhengzhou University, and according to whether they participated in literature reading report, they were divided into participating group with 38 students and non-participating group with 53 students. The method of questionnaire combined with interview was used to investigate the implementation of literature reading report, the willingness to participate in literature reading report, and the current status of clinical research ability. SPSS 25.0 was used to perform the chi-square test and the Wilcoxon rank-sum test.Results:In the participating group, 60.53% (23/38) of the students thought that there was a significant improvement in clinical research ability after literature reading report, and in the non-participating group, 94.12% (48/51) of the students wanted to carry out literature reading report. Compared with the non-participating group, the participating group had significantly higher publication rate, project participation rate, academic exchange rate, and literature reading quantity ( P<0.05) and significantly better abilities of literature search and reading, professional English, and PPT presentation ( P<0.05), while there were no significant differences between the two groups in the scores of statistical analysis ability, project design ability, clinical thinking ability, and evidence-based medicine ability ( P>0.05). Conclusions:Literature reading report can promote the improvement in clinical research ability among professional postgraduate students in pediatrics, and it should be carried out regularly for a long time with adherence to the principle of clinical orientation and emphasis on the reading of methodology and statistics in literature.
3.Influencing factors of frailty in lung transplant patients:a Meta-analysis
Peipei GU ; Fei ZENG ; Meijuan LAN ; Jiangshuyuan LIANG ; Luyao GUO ; Lingyun CAI ; Yan ZHU ; Ge GUO
Chinese Journal of Nursing 2024;59(9):1122-1129
Objective To identify the factors associated with frailty in lung transplant patients by a meta-analysis.Methods Computerized search was performed for studies on the influencing factors of frailty in lung transplant patients in the CNKI,WanFangData,VIP,CBM,PubMed,Web of Science,Embase,Elsevier ScienceDirect and CINAHL databases.The search was conducted from the time of database construction to November 2023.Literature screening,quality assessment,and data extraction were performed independently by 2 investigators,and Meta-analysis was performed using Stata 17.0 software.Results 10 cohort studies,including 1 999 patients,were finally included,and 13 influencing factors were extracted,including advanced age(OR=1.05),female(OR=2.50),BMI(OR=0.38),diagnosis of primary pulmonary disease(OR=2.90),6MWD(OR=0.34),and lung allocation score(OR=0.69),FVC(OR=0.60),pre-transplant frailty(OR=0.81),hypoproteinemia(OR=4.12),hemoglobin(OR=0.50),anemia(OR=4.37),length of ICU stay(OR=1.24),and total length of stay(OR=1.05).Short Physical Performance Battery is an assessment tool for frailty in lung transplant patients,with an incidence of frailty in 24%before transplantation and 50%in post-transplantation.Fried Frailty Phenotype is an assessment tool for frailty in lung transplant patients,with a pre-transplant frailty incidence of 30%.Conclusion There are many factors involved in the incidence of frailty in lung transplant patients,and nursing staff should dynamically evaluate the frailty of lung transplant patients,and give individualized and precise interventions in combination with a multidisciplinary model to improve or delay the progression of frailty.
4.Effects of remote interventions with digital health technologies in lung transplant patients:a meta-analysis
Ge GUO ; Meijuan LAN ; Fei ZENG ; Jiangshuyuan LIANG ; Luyao GUO ; Lingyun CAI ; Peipei GU ; Yan ZHU
Chinese Journal of Nursing 2024;59(11):1389-1396
Objective To evaluate the effect of remote interventions with digital health technologies in lung transplant patients.Methods Databases,including CKNI,Wangfang,VIP,CMB,Cochrane Library,PubMed,Embase,Web of Science,Scopus and BMJ Best Practice were searched from their inception to July 2023.There were 2 researchers who independently screened and extracted the literature,and then evaluated quality of the included studies.Meta-analysis was performed using RevMan 5.2.Results 10 studies with 1 262 patients were included.The results of meta-analysis showed that compared with conventional intervention,remote intervention based on digital health technology could improve self-monitoring compliance of lung transplant patients[0R=0.64,95%CI(0.46,0.88),P=0.006],improve quality of life including mental health status[OR=3.08,95%CI(0.41,5.74),P=0.020]and physical health status[OR=3.81,95%CI(1.19,6.43),P=0.004].In terms of the intervention forms,the application-based remote intervention had better self-monitoring compliance,and the difference was statistically significant(P=0.007).However,in terms of the comparison of readmission rate[OR=1.73,95%CI(0.98,3.04),P=0.060],anxiety[OR=-0.12,95%CI(-1.36,1.11),P=0.850],and depression[OR=0.62,95%CI(-0.80,2.03),P=0.390],the effect of intervention was unclear.Conclusion Remote intervention based on digital health technology can improve self-monitoring compliance and quality of life in lung transplant patients;applications are the optimal form of intervention.Limited by the quality and quantity of included studies and the heterogeneity of study results,more high-quality studies are needed to further verify the effects of digital health technology on readmission rates,anxiety and depression of lung transplant patients.
5.Continued nursing in a patient with combined liver-lung transplantation
Jiangshuyuan LIANG ; Fei ZENG ; Peipei GU
Chinese Journal of Nursing 2024;59(12):1497-1500
To summarize the continued nursing management of a patient with combined liver-lung transplantation.Nursing points:regular review and joint remote guidance;dynamic optimization of the rehabilitation program;strict control of blood concentration of Tacrolimus;the strengthening of infection prevention and control;standardized management of post-transplant diabetes mellitus;active interventions in osteoporosis;helping patients to self-empower and achieve all-round rehabilitation.In 2 years and 8 months after surgery,the follow-up showed that the patient had normal transplant organ function and good quality of life.
6.Analysis and nursing enlightenment of influencing factors of post-transplant diabetes mellitus in lung transplant recipients
Lingyun CAI ; Fei ZENG ; Luyao GUO ; Meijuan LAN ; Jiangshuyuan LIANG ; Peipei GU ; Yan ZHU ; Ge GUO
Chinese Journal of Nursing 2024;59(16):1987-1992
Objective To investigate the incidence and risk factors of post-transplant diabetes mellitus(PTDM)in adult lung transplant recipients.Methods Conducting a convenience sampling method,we retrospectively analyzed the clinical data of lung transplant recipients from January 2020 to December 2022 at a tertiary A hospital in Hangzhou,Zhejiang Province.According to the PTDM diagnostic criteria,lung transplant recipients are divided into a PTDM group and a non-PTDM group.The incidence rate of PTDM is calculated,and the influencing factors for PTDM occurrence are analyzed using both univariate and multivariate logistic regression methods.Results A total of 140 patients were included in this study,and 54 lung transplant recipients developed PTDM within 6 months,with an incidence of 38.57%.Univariate analysis showed that there were significant differences in age,gender,BMI,smoking history,pre-operative glycated albumin,pre-operative fasting blood glucose,early post-operative blood glucose and pre-operative creatinine between the 2 groups(P<0.05).Multivariate Logistic analysis showed that gender(OR=5.283),BMI(OR=6.122),pre-operative glycated albumin(OR=1.330),and early post-operative blood glucose(0R=1.444)were the influencing factors.Conclusion Lung transplant recipients who were male,BMI ≥24.0,with high levels of glycated albumin before surgery,and high blood sugar early after surgery had a higher risk of developing PTDM.Clinical nurses can formulate relevant nursing measures according to the influencing factors to prevent the occurrence of PTDM.
7.Nursing care of a patient with right-to-left inverted lung transplantation
Fei ZENG ; Meijuan LAN ; Jiangshuyuan LIANG ; Peipei GU
Chinese Journal of Nursing 2024;59(17):2134-2137
The nursing experience of a patient with right-to-left inverted lung transplantation was summarized.The key points of nursing care:closely monitoring frequent arrhythmiac;developing excessive pulmonary rehabilitation strategies based on heart rate;being alert to carbon dioxide retention caused by pulmonary insufficiency;performing non-invasive ventilation combined with nitric oxide inhalation for pulmonary hypertension care;early identification and management of gastrointestinal dysfunction;and strengthening the prevention and management of complications.After fine care,the patient recovered well,and the transplanted lung function was normal,and he was discharged smoothly.
8.Effect of Modified Shengjiangsan on Gd-IgA1 in IgA Nephropathy Rats: Based on C1GALT1/C1GALT1C1 Signaling Pathway
Yuanyuan ZHANG ; Peipei JIN ; Hechao JIN ; Yue GU ; Dengzhou GUO
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(14):70-80
ObjectiveThe effect of modified Shengjiangsan on immunoglobulin A (IgA) nephropathy was observed. The microRNA-148b (miRNA-148b), interleukin 6 (IL-6), core 1 beta 1,3-galactosyltransferase (C1GALT1), molecular chaperone Cosmc (core1β3-Gal-T-specific molecular chaperone C1GALT1C1), and galactose-deficient IgA1 (Gd-IGA1) in serum and kidney tissues of IgA nephropathy rats were detected to explore the underlying mechanism. The result is expected to lay a scientific basis for clinical application of modified Shengjiangsan in the treatment of IgA nephropathy. MethodA total of 42 SPF male SD rats were randomized into the normal group (8rats) and modeling group (34 rats) with the random number table method. After one week of adaptive feeding, rats for modeling were given bovine serum albumin (BSA, gavage), lipopolysaccharide (LPS, injection into tail vein), carbon tetrachloride (CCl4, subcutaneous injection), and castor oil to induce IgA nephropathy. After modeling, two rats were randomly selected to test the modeling outcome. Then the model rats were classified into the model group, low-dose Chinese medicine group (modified Shengjiangsan,6.27 g·kg-1), high-dose Chinese medicine group (modified Shengjiangsan,12.54 g·kg-1), and benazepril group (10 mg·kg-1) with the random number table method, 8 in each group. The administration (gavage, once a day) lasted 4 weeks. The 24-h urinary total protein (24 h-UTP) was detected at the end of the 1st, 9th, and 13th week of the experiment. At the 14th week, after anesthesia, femoral artery blood was collected and centrifugated. The supernatant was collected to detect albumin (ALB), aspartate aminotransferase (AST), alanine aminotransferase (ALT), serum creatinine (SCr), and blood urea nitrogen (BUN). The expression levels of IL-6 and Gd-IGA1 were determined by enzyme-linked immunosorbent assay (ELISA). Based on hematoxylin-eosin (HE)/Masson/periodic Schiff-methenamine silver (PASM) staining, the pathological changes of renal tissues were observed. Ultrastructural changes of glomeruli were observed by transmission electron microscopy. The expression of miRNA-148b, IL-6, C1GALT1, and C1GALT1C1 was detected by immunohistochemistry. The mesangial area of the glomeruli was observed by immunofluorescence. Real-time polymerase chain reaction (Real-time PCR) was employed to determine the mRNA levels of mirNA-148b, IL-6, C1GALT1, and C1GALT1C1, and Western blot was used to detect the protein levels of IL-6, C1GALT1, and C1GALT1C1. ResultCompared with normal group, the model group showed increase in the content of 24 h-UTP, SCr, ALT, IL-6, and GD-IGA1 (P<0.05), decrease in ALB content (P<0.05). Moreover, rats in the model group demonstrated hyperplasia of glomerular mesangial cells, thickening of mesangial area, podocyte foot process effacement, and a large number of granular IgA immune complex in the mesangial area. In addition, the model group showed increase in the expression of IL-6 in mesangial area and podocytes, decrease in the expression of C1GALT1 and C1GALT1C1 in mesangial area and podocytes, enhanced expression of IL-6 mRNA and miRNA-148b (P<0.01), weakened expression of C1GALT1 mRNA and C1GALT1C1 mRNA (P<0.01), rise of IL-6 protein expression (P<0.01), and reduction in the protein expression of C1GALT1 and C1GALT1C1 (P<0.01). Compared with the model group, modified Shengjiangsan decreased the content of 24 h-UTP, SCr, ALT, IL-6, and Gd-IGA1 (P<0.05) and increased the content of ALB (P<0.05, P<0.01). Moreover, with the treatment of this Chinese medicine, the pathological damage was significantly alleviated and the deposition of IgA immune complex in basement membrane was reduced. The expression of IL-6 in the mesangial area and podocytes of rats was decreased, and the expression of C1GALT1 and C1GALT1C1 in the mesangial area and podocytes of rats was increased. Moreover, the expression of IL-6 mRNA and miRNA-148b was decreased (P<0.01), and the expression of C1GALT1 mRNA and C1GALT1C1 mRNA was increased (P<0.01). The protein expression of IL-6 was decreased (P<0.05, P<0.01), and the protein expression of C1GALT1 and C1GALT1C1 was enhanced (P<0.05, P<0.01). The Chinese medicine group showed obvious dose-effect trend. ConclusionModified Shengjiangsan may reduce the expression of miRNA-148b and IL-6 in serum and kidney tissue of IgA nephropathy rats, restore the expression of C1GALT1 and C1GALT1C1, and decrease the generation of Gd-IGA1, so as to reduce renal pathological damage and proteinuria, protect the kidney protection, and finally delay the disease progression. Moreover, the effect is enhanced with the rise of dose.
9.Expert consensus on prevention and management of enteral nutrition therapy complications for critically ill patients in China (2021 edition)
Yuanyuan MI ; Haiyan HUANG ; You SHANG ; Xiaoping SHAO ; Peipei HUANG ; Chenglin XIANG ; Shuhua WANG ; Lei BAO ; Lanping ZHENG ; Su GU ; Yun XU ; Chuansheng LI ; Shiying YUAN
Chinese Critical Care Medicine 2021;33(8):903-918
Enteral nutrition plays an irreplaceable role in the nutritional treatment of critically ill patients. In order to help clinical medical staff to manage the common complications during the implementations of enteral nutrition for critically ill patients, the consensus writing team carried out literature retrieval, literature quality evaluation, evidence synthesis. Several topics such as diarrhea, aspiration, high gastric residual volume, abdominal distension, etc. were assessed by evidence-based methodology and Delphi method. After two rounds of expert investigations, Expert consensus on prevention and management of enteral nutrition therapy complications for critically ill patients in China (2021 edition) developed, and provided guidance for clinical medical staff.
10.BRICS report of 2018-2019: the distribution and antimicrobial resistance profile of clinical isolates from blood culture in China
Yunbo CHEN ; Jinru JI ; Chaoqun YING ; Peipei WANG ; Zhiying LIU ; Qing YANG ; Haishen KONG ; Hui DING ; Yongyun LIU ; Haifeng MAO ; Ying HUANG ; Zhenghai YANG ; Yuanyuan DAI ; Guolin LIAO ; Lisha ZHU ; Liping ZHANG ; Yanhong LI ; Hongyun XU ; Junmin CAO ; Baohua ZHANG ; Liang GUO ; Haixin DONG ; Shuyan HU ; Sijin MAN ; Lu WANG ; Zhixiang LIAO ; Rong XU ; Dan LIU ; Yan JIN ; Yizheng ZHOU ; Yiqun LIAO ; Fenghong CHEN ; Beiqing GU ; Jiliang WANG ; Jinhua LIANG ; Lin ZHENG ; Aiyun LI ; Jilu SHEN ; Yinqiao DONG ; Lixia ZHANG ; Hongxia HU ; Bo QUAN ; Wencheng ZHU ; Kunpeng LIANG ; Qiang LIU ; Shifu WANG ; Xiaoping YAN ; Jiangbang KANG ; Xiusan XIA ; Lan MA ; Li SUN ; Liang LUAN ; Jianzhong WANG ; Zhuo LI ; Dengyan QIAO ; Lin ZHANG ; Lanjuan LI ; Yonghong XIAO
Chinese Journal of Clinical Infectious Diseases 2021;14(1):32-45
Objective:To investigate the distribution and antimicrobial resistance profile of clinical bacteria isolated from blood culture in China.Methods:The clinical bacterial strains isolated from blood culture from member hospitals of Blood Bacterial Resistant Investigation Collaborative System (BRICS) were collected during January 2018 to December 2019. Antibiotic susceptibility tests were conducted with agar dilution or broth dilution methods recommended by US Clinical and Laboratory Standards Institute (CLSI). WHONET 5.6 was used to analyze data.Results:During the study period, 14 778 bacterial strains were collected from 50 hospitals, of which 4 117 (27.9%) were Gram-positive bacteria and 10 661(72.1%) were Gram-negative bacteria. The top 10 bacterial species were Escherichia coli (37.2%), Klebsiella pneumoniae (17.0%), Staphylococcus aureus (9.7%), coagulase-negative Staphylococci (8.7%), Pseudomonas aeruginosa (3.7%), Enterococcus faecium (3.4%), Acinetobacter baumannii(3.4%), Enterobacter cloacae (2.9%), Streptococci(2.8%) and Enterococcus faecalis (2.3%). The the prevalence of methicillin-resistant S. aureus (MRSA) and methicillin-resistant coagulase-negative Staphylococcus were 27.4% (394/1 438) and 70.4% (905/1 285), respectively. No glycopeptide-resistant Staphylococcus was detected. More than 95% of S. aureus were sensitive to amikacin, rifampicin and SMZco. The resistance rate of E. faecium to vancomycin was 0.4% (2/504), and no vancomycin-resistant E. faecalis was detected. The ESBLs-producing rates in no carbapenem-resistance E. coli, carbapenem sensitive K. pneumoniae and Proteus were 50.4% (2 731/5 415), 24.6% (493/2001) and 35.2% (31/88), respectively. The prevalence of carbapenem-resistance in E. coli and K. pneumoniae were 1.5% (85/5 500), 20.6% (518/2 519), respectively. 8.3% (27/325) of carbapenem-resistance K. pneumoniae was resistant to ceftazidime/avibactam combination. The resistance rates of A. baumannii to polymyxin and tigecycline were 2.8% (14/501) and 3.4% (17/501) respectively, and that of P. aeruginosa to carbapenem were 18.9% (103/546). Conclusions:The surveillance results from 2018 to 2019 showed that the main pathogens of bloodstream infection in China were gram-negative bacteria, while E. coli was the most common pathogen, and ESBLs-producing strains were in majority; the MRSA incidence is getting lower in China; carbapenem-resistant E. coli keeps at a low level, while carbapenem-resistant K. pneumoniae is on the rise obviously.

Result Analysis
Print
Save
E-mail